Shasun Of India Sees Double Sales Selling Ingredients Of Expiring Drugs
This article was originally published in PharmAsia News
India's Shasun Pharmaceuticals expects to double its sales in the next three years based on supplying to generic drug makers the main ingredients for patent-losing drugs, such as of Pfizer's Advil (chlorpheniramine).
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.